Substantial improvement in a Meige's syndrome patient with levetiracetam treatment

We report on a woman with idiopathic Meige's syndrome whose dystonia improved with the use of levetiracetam (LEV, Keppra, UCB Pharma, Smyrna, GA). This report and data from an animal model of paroxysmal dystonia suggest that LEV might be helpful in the treatment of dystonia. © 2004 Movement Dis...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Movement disorders 2004-12, Vol.19 (12), p.1518-1521
Hauptverfasser:	Zesiewicz, Theresa A., Louis, Elan D., Sullivan, Kelly L., Menkin, Martin, Dunne, Peter B., Hauser, Robert A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Anticonvulsants - therapeutic use Biological and medical sciences cervical dystonia Female Humans Injuries of the nervous system and the skull. Diseases due to physical agents Keppra levetiracetam Medical sciences Meige Syndrome - diagnosis Meige Syndrome - drug therapy Meige Syndrome - physiopathology Meige's syndrome Middle Aged Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis Neurology Piracetam - analogs & derivatives Piracetam - therapeutic use Severity of Illness Index Traumas. Diseases due to physical agents Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	We report on a woman with idiopathic Meige's syndrome whose dystonia improved with the use of levetiracetam (LEV, Keppra, UCB Pharma, Smyrna, GA). This report and data from an animal model of paroxysmal dystonia suggest that LEV might be helpful in the treatment of dystonia. © 2004 Movement Disorder Society
ISSN:	0885-3185 1531-8257
DOI:	10.1002/mds.20233